FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Petros Karamanakos

Research Profile

Chemicals & Drugs

Living Beings

Co-author Network

Publications

TOP 3
Petros N Karamanakos; Stepani Bendel; Juha Hernesniemi; Terhi Huttunen; Juha E Jaaskelainen; Mitja Kurki; Jaakko Rinne; Antti Ronkainen; Mikael von und zu Fraunberg; Timo Koivisto
Risk factors for three phases of 12-month mortality in 1657 patients from a defined population after acute aneurysmal subarachnoid hemorrhage.
Petros N Karamanakos
Comment on: Chlorpheniramine exerts anxiolytic-like effects and activates prefrontal 5-HT systems in mice (Miyata S. et al., Psychopharmacology, 2009).
Petros N Karamanakos; Timo Koivisto; Ritva Vanninen; Mohammad Khallaf; Antti Ronkainen; Ilkka Parviainen; Hannu Manninen; Mikael von und zu Fraunberg; Michael K Morgan; Juha E Jaaskelainen; Juha Hernesniemi; Jaakko Rinne
The impact of endovascular management on the outcome of aneurysmal subarachnoid hemorrhage in the elderly in eastern Finland.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Petros Karamanakos (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Petros N Karamanakos; Stepani Bendel; Juha Hernesniemi; Terhi Huttunen; Juha E Jaaskelainen; Mitja Kurki; Jaakko Rinne; Antti Ronkainen; Mikael von und zu Fraunberg; Timo Koivisto
Risk factors for three phases of 12-month mortality in 1657 patients from a defined population after acute aneurysmal subarachnoid hemorrhage.
World neurosurgery 2012;78(6):631-9.
2011: Petros N Karamanakos
Comment on: Chlorpheniramine exerts anxiolytic-like effects and activates prefrontal 5-HT systems in mice (Miyata S. et al., Psychopharmacology, 2009).
Psychopharmacology 2011;213(2-3):647; author reply 649.
2010: Petros N Karamanakos; Timo Koivisto; Ritva Vanninen; Mohammad Khallaf; Antti Ronkainen; Ilkka Parviainen; Hannu Manninen; Mikael von und zu Fraunberg; Michael K Morgan; Juha E Jaaskelainen; Juha Hernesniemi; Jaakko Rinne
The impact of endovascular management on the outcome of aneurysmal subarachnoid hemorrhage in the elderly in eastern Finland.
Acta neurochirurgica 2010;152(9):1493-502.
2010: Petros N Karamanakos; Juha E Jaaskelainen; Irina Alafuzoff; Elina Pirinen; Ritva Vanninen; Sanna Silvennoinen; Ulla Sankilampi; Arto Immonen
Malignant giant cell tumor in the posterior fossa of a neonate.
Journal of neurosurgery. Pediatrics 2010;5(3):277-82.
2010: Dimitrios T Trafalis; Eleftheria S Panteli; Anastasios Grivas; Christos Tsigris; Petros N Karamanakos
CYP2E1 and risk of chemically mediated cancers.
Expert opinion on drug metabolism & toxicology 2010;6(3):307-19.
2009: Petros N Karamanakos; D T P Trafalis; G D Geromichalos; Periklis Pappas; Panagiotis Harkitis; Maria Konstandi; Marios Marselos
Inhibition of rat hepatic CYP2E1 by quinacrine: molecular modeling investigation and effects on 4-(methyl nitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced mutagenicity.
Archives of toxicology 2009;83(6):571-80.
2008: Petros N Karamanakos
Furazolidone and serotonin syndrome: is there any association?
Clinics (São Paulo, Brazil) 2008;63(4):553-4.
2008: Petros N Karamanakos
Intoxication with over-the-counter antitussive medication containing dihydrocodeine and chlorpheniramine causes generalized convulsion and mixed acidosis.
Internal medicine (Tokyo, Japan) 2008;47(20):1821; author reply 1823.
2008: Petros N Karamanakos; Periklis Pappas; Marios Marselos
Possible role for chlorpheniramine in the treatment of L-DOPA induced dyskinesia in Parkinson's disease.
Pharmacy world & science : PWS 2008;30(1):1-2.
2007: Petros N Karamanakos; Periklis Pappas; Vassiliki A Boumba; Christoforos Thomas; Michail Malamas; Theodre Vougiouklakis; Marios Marselos
Pharmaceutical agents known to produce disulfiram-like reaction: effects on hepatic ethanol metabolism and brain monoamines.
International journal of toxicology 2007;26(5):423-32.
2007: Petros N Karamanakos
Can chlorpheniramine cause serotonin syndrome?
Singapore medical journal 2007;48(5):482; author reply 483.
2004: Petros N Karamanakos; Periklis Pappas; Marios Marselos
Involvement of the brain serotonergic system in the locomotor stimulant effects of chlorpheniramine in Wistar rats: implication of postsynaptic 5-HT1A receptors.
Behavioural brain research 2004;148(1-2):199-208.
2003: Periklis Pappas; Maria Sotiropoulou; Petros N Karamanakos; Angeliki Kostoula; Stamatina Levidiotou; Marios Marselos
Acute-phase response to benzo[a]pyrene and induction of rat ALDH3A1.
Chemico-biological interactions 2003;143-144():55-62.
2001: Petros N Karamanakos; Periklis Pappas; P Stephanou; Marios Marselos
Differentiation of disulfiram effects on central catecholamines and hepatic ethanol metabolism.
Pharmacology & toxicology 2001;88(2):106-10.
2001: Periklis Pappas; P Stephanou; Petros N Karamanakos; V Vasiliou; Marios Marselos
Phenobarbital inducibility and differences in protein expression of an animal model.
Chemico-biological interactions 2001;130-132(1-3):275-83.
1999: Marios Marselos; Petros N Karamanakos
Mutagenicity, developmental toxicity and carcinogenicity of cannabis.
Addiction biology 1999;4(1):5-12.
1997: Periklis Pappas; P Stephanou; V Vasiliou; Petros N Karamanakos; Marios Marselos
Ontogenesis and expression of ALDH activity in the skin and the eye of the rat.
Advances in experimental medicine and biology 1997;414():73-80.